Originally published In Press as doi:10.1074/jbc.M109869200 on February 7, 2002
J. Biol. Chem., Vol. 277, Issue 16, 13443-13448, April 19, 2002
Formation of Inactive cAMP-saturated Holoenzyme of
cAMP-dependent Protein Kinase under Physiological
Conditions*
Reidun
Kopperud
,
Anne Elisabeth
Christensen
,
Endre
Kjærland,
Kristin
Viste,
Hans
Kleivdal, and
Stein Ove
Døskeland§
From the Department of Anatomy and Cell Biology, University of
Bergen, N-5009 Bergen, Norway
Received for publication, October 12, 2001, and in revised form, January 2, 2002
 |
ABSTRACT |
The complex of the subunits (RI
, C
) of
cAMP-dependent protein kinase I (cA-PKI) was much more
stable (Kd = 0.25 µM) in the presence
of excess cAMP than previously thought. The ternary complex of C
subunit with cAMP-saturated RI
or RII
was devoid of catalytic
activity against either peptide or physiological protein substrates.
The ternary complex was destabilized by protein kinase substrate.
Extrapolation from the in vitro data suggested about
one-fourth of the C subunit to be in ternary complex in maximally
cAMP-stimulated cells. Cells overexpressing either RI
or RII
showed decreased CRE-dependent gene induction in response to maximal cAMP stimulation. This could be explained by enhanced ternary complex formation. Modulation of ternary complex formation by
the level of R subunit may represent a novel way of regulating the cAMP
kinase activity in maximally cAMP-stimulated cells.
 |
INTRODUCTION |
The cAMP-dependent protein kinase
(cA-PK)1 differs from other
kinases in having the catalytic site and the autoinhibitory site on two
different subunits. The inactive cA-PK holoenzyme, when studied at
nanomolar concentrations, dissociates into catalytic (C) and regulatory
(R) subunits in the presence of cAMP (1). There is sparse evidence
about the behavior of cA-PK at higher, more physiologically relevant,
concentrations. Apparently, it is tacitly assumed that both isozymes
(cA-PKI and cA-PKII) are completely dissociated by cAMP in the intact
cell. The cAMP-induced decrease of fluorescent resonance transfer
between microinjected C
-FITC and RI
-TRITC (2), and between
genetically encoded fluorescent C
and RII
(3) has reinforced this
notion, although such studies are not designed to tell whether the
dissociation of cA-PK is complete or not (4). Recently, C/EBP
null
mice were shown to have increased liver RI and RII, and attenuated cAMP-stimulated hepatic gene induction (5). Protein kinase inhibitor
null mice, having 50% increased muscle RI
, showed deficient cAMP-stimulated CREB phosphorylation and CRE-dependent gene
expression in muscle (6). We have previously observed relatively more holoenzyme-associated kinase than expected from the tissue cAMP content
during the pre-replicative cAMP surge in the regenerating liver, in
which both RI and RII were up-regulated (7). These observations suggest
the possibility that RI or RII subunits may have a negative effect on
cA-PK dissociation even at high cAMP concentrations. We used the
CRE-luciferase reporter gene to probe for dissociation of cA-PKI and
cA-PKII in intact cells. Nuclear translocation of the C subunit
requires cA-PK dissociation and is considered a prerequisite for
phosphorylation of the CREB/CREM family of nuclear transcription
factors, and hence for cAMP stimulation of CRE-governed reporter gene
expression (8-10). We show that cells overexpressing either hRI
or
hRII
, even when maximally cAMP challenged, had decreased cAMP
responsive gene induction, suggesting that cAMP produced incomplete
dissociation of either isozyme in intact cells. We will also present
evidence that the affinity between RI and C subunits in the presence of
saturating cAMP is 1 to 2 orders of magnitude higher than hitherto
assumed (11).
The presence of a substantial amount of ternary complex of cAMP, R and
C in intact cells actualizes the unresolved issue of whether the cA-PK
holoenzyme has any catalytic activity in the presence of cAMP (12).
Several arguments have been provided in favor of this possibility. The
cGMP-dependent protein kinase, which is highly homologous
to cA-PK (13), is activated by cGMP without dissociation (12). The RII
subunit of cA-PK type II mutagenized in the substrate motif was able to
form holoenzyme without blocking the C activity (14). The
cAMP-saturated cA-PKII holoenzyme was reported to be fully active (15),
and this observation was linked to the fact that most cA-PK anchoring
proteins (AKAPs) preferentially bind RII (16, 17). In several cases the
disruption of R binding to AKAPs blocks the cAMP control of specific
substrate proteins (18). This is more easily explained if cA-PK is
catalytically active while physically retained in a supramolecular
complex with its substrate, than if activation involves dissociation of
the C subunit from the AKAP-anchored R subunit. We show that neither cA-PKI nor cA-PKII had significant catalytic activity against synthetic
or physiological substrate under near physiological in vitro conditions.
 |
EXPERIMENTAL PROCEDURES |
Fluorescein 5-isothiocyanate (FITC) and
tetramethylrhodamine-5-isothiocyanate (TRITC) were from Molecular
Probes, Eugene, OR. EZ-Link Sulfo-NHS-LC-LC-Biotin was from Pierce.
Streptavidin-coated 96-well "Flashplates" were from PerkinElmer
Life Science. Cyclic AMP analogs were purchased from Biolog Life
Science, Bremen, Germany. The heptapeptide LRRASLG (Kemptide), 99%
purity, and most other chemicals were from Sigma.
[8-3H]Adenosine 3',5'-cyclic phosphate and
[
-32P]ATP were from Amersham Bioscience,
Buckinghamshire, UK. Recombinant human phenylalanine 4-monooxygenase
(PAH) and tyrosine 4-monooxygenase (TH) was from Dr. Torgeir Flatmark,
University of Bergen, Norway. pUC7/RI
containing bovine RI
cDNA was kindly provided by Dr. Susan Taylor, University of
California, San Diego (19). pGEX-KG/hRI
and pGEX-KG/hRII
containing full-length cDNA of human RI
and RII
fused to GST,
was kindly provided by Dr. Kjetil Taskén, University of Oslo,
Norway. His6hRI
and His6hRII
were
constructed by subcloning the RI
/RII
cDNA into pBAD
(CLONTECH). For cell transfection, RI
and
RII
cDNAs were subcloned into pcDNA (Invitrogen). The
pCMV5-C
plasmid was a kind gift from Dr. Stanley McKnight, University of Washington, Seattle, WA. The luciferase reporter plasmid,
pT81-4CRE-Luc was a kind gift from Dr. Marit Bakke, University of
Bergen, Norway. The green fluorescent protein plasmid pGFP-C1 was from
CLONTECH. Buffer A is a near physiological buffer
with respect to pH, ionic strength, potassium, phosphate, and magnesium concentration, and consists of 15 mM Hepes, pH 7.2, 1 mM Na2PO4, 130 mM KCl,
0.3 mM ATP, 2 mM
Mg(CH3COO)2, 0.3 mM EGTA, 1 mM EDTA, 0.1 mM dithioerythritol.
Cell Culture and Transfection--
HEK 293 cells were seeded at
a density of 2 × 105 cells/cm2 in a
6-well plate and transfected 24 h later by calcium phosphate precipitation with reporter plasmid (0.16 µg of pT81-4CRE-Luc), various concentrations of pCMV5-C
, pcDNA-hRI
, or
pcDNA-hRII
. The total amount of plasmid was kept constant (2 µg) by compensating with pCMV5 empty vector. The cells were washed
once with phosphate-buffered saline 24 h after
transfection, lysed in 80 µl of 25 mM Tris, 1 mM EDTA, 10% glycerol, 1% Triton X-100, and 2 mM dithiothreitol, and assayed for luciferase activity.
Some of the cultures had received treatment with cAMP elevating agents
(30 µM forskolin, 250 µM
isobutylmethylxanthine) and cAMP analogs (1 mM
8-chlorophenylthio-cAMP, 0.7 mM
N6-monobutyryl-cAMP, and 0.7 mM
N6-benzoyl-cAMP) the last 3 h before
harvesting. The transfection efficiency of the HEK 293 cells was
determined by replacing pT81-4CRE-Luc with 0.1 µg of pGFP-C1, and
visualization of green fluorescent cells 24 h after transfection.
Purification of Proteins--
The C
subunit was
purified from 12 kg of bovine heart. The 10,000 × g
supernatant after homogenization in 10 mM KPO4,
1 mM EDTA, 0.1 mM dithioerythritol was passed
through P1-cellulose, applied to DEAE-Sepharose (1.5 liters), washed
with 80 liters of 55 mM KPO4, pH 6.8, 1 mM EDTA, 0.1 mM dithioerythritol, and C
eluted with 0.1 mM cAMP in 50 mM
KPO4, 1 mM EDTA, 0.1 mM
dithioerythritol. Active fractions were diluted 3-fold in water,
chromatographed on SP-Sepharose, and eluted with a linear KCl gradient
(0 to 500 mM). The 99% pure enzyme was applied on a
hydroxylapatite column, and eluted in 5 ml of 600 mM
KPO4 at a concentration of 0.3 mM.
Recombinant human R subunits were harvested from transformed
Escherichia coli BL21, bovine R subunit from E. coli E222. Bovine RI was purified by ammonium sulfate
precipitation and DEAE-Sepharose chromatography. His-tagged R was
purified on Ni2+-NTA chromatography, and GST-tagged R by
GSH affinity chromatography. Thrombin cleavage to separate GST and R
was performed with GST-R still bound to resin. For final purification
the R subunits were subjected to FPLC size exclusion chromatography on
a column equilibrated in buffer A without ATP.
Labeling of cAMP-dependent Protein Kinase Subunits,
Determination of Fluorescence Energy Transfer (FRET), and Scintillation
Proximity Assay--
Commercially available C-FITC and R-TRITC had
decreased specific kinase activity and decreased affinity for C
subunit, respectively. We therefore labeled bovine C
subunit with
FITC and bovine RI
subunit with TRITC according to Adams (2). The
C
subunit was biotinylated when in holoenzyme complex to protect the
R-C interaction face from modification. The cA-PKI holoenzyme (2 mg/ml)
was mixed with 0.6 mg/ml EZ-Link Sulfo-NHS-LC-LC-Biotin (Pierce), and
reacted for 0.5 h at room temperature. Free biotin-C
subunit
was obtained by FPLC (Superdex 200) in 50 mM phosphate
buffer with 30 µM cAMP. The C-FITC and the biotinylated C
subunit had the same molar activity (18 s
1) as unmodified
C, and similar efficiency in releasing [3H]cAMP bound to
RI
. Cyclic AMP bound to RI-TRITC with the same affinity as to
unmodified RI, and the C subunit released [3H]cAMP from
complex with RI-TRITC and RI at similar rate (not shown). For
determination of FRET, subunits incubated in a 0.5 ml cuvette, were
excited (Xenon lamp) at 490 nm, and emission determined at 510 and 580 nm (by PTI photomultiplier) before and after addition of 50 µM cAMP. For scintillation proximity assay, streptavidin-coated flashplates (PerkinElmer Life Science) were coated
with the biotin-C
and washed with buffer A with 5 mg/ml serum
albumin. RI
(10-2600 nM), that had been fully exchanged with [3H]cAMP, was incubated in buffer A with 1.25-2.5
µM [3H]cAMP in the C subunit-coated
wells. After 1 h of incubation at 4 °C, plates were counted at
25 °C (TopCount-NXT, Packard).
Assay of Protein Kinase Activity and of R Subunit
[3H]cAMP Binding Activity--
Kinase incubations were
in buffer A with [
-32P]ATP. The phosphorylation of
Kemptide was determined as described in Refs. 7 and 20 and
phosphorylation of PAH according to Ref. 21. For TH phosphorylation,
aliquots were mixed with sample buffer for SDS-PAGE (22), and
32P-RII and [32P]TH detected by
autoradiography after separation by SDS-PAGE. The level of C and
R subunits of cA-PK in cell extracts was determined as described
previously (7), except that the total level of R subunits (RI + RII)
was determined by the ammonium sulfate precipitation method (23).
Estimation of the Level of R and C Subunits of cA-PK, and of C
Subunit Occupation by Substrate in Intact cAMP-stimulated Cells--
A
thorough study (24) showed equimolar expression of the R (RI + RII) and
C subunits of cA-PK in mammalian tissue, averaging 0.3 pmol/mg tissue,
wet weight. This translates to an average intracellular concentration
of subunits of about 0.5 µM, assuming the extracellular
space to occupy 15% of the tissue, and the subunits to distribute in
70% of the intracellular space. The presently studied HEK293 cells had
3.3 pmol of R subunit/mg of protein and 3.0 pmol of C subunit/mg of
protein (see first paragraph under "Results"). Assuming that the
cells contained 10% protein, this value translates to about 0.3 pmol
of subunit/mg of cellular wet weight, which means that the
untransfected HEK293 cells had an average level of cA-PK subunit expression.
The free C subunit encounters substrates in the cell, but the % substrate saturation is unknown. To obtain an estimate, the rate of
phosphorylation of PAH in vitro in the absence of competing substrates, was compared with the rate in intact, cAMP-stimulated hepatocytes (21). The phosphorylation was about 8 times slower in the
intact cell, suggesting that one-eighth of the C subunit pool was
accessible for PAH phosphorylation, and that at most seven-eights of it
(85-90%) was occupied by other substrates.
 |
RESULTS |
Enforced Expression of RI
or RII
Attenuates cAMP-induced
CRE-mediated Gene Induction--
HEK 293 cells were co-transfected
with pT81-4CRE-Luc and expression vector containing either RI
or
RII
, to study the effect of overexpressed RI and RII subunits on
gene transcription via the cAMP-responsive element (CRE). The cells
were stimulated with agents elevating the endogenous cAMP as well as
potent cAMP analogs to ensure full saturation of the R subunits of
cA-PK. It was found that cells overexpressing RI
or RII
had about
half as strong luciferase induction by cAMP agonists as control cells
(Fig. 1A). A similarly blunted
luciferase induction was noted in RI
overexpressing cells exposed to
potent acetoxy-methylated cAMP analogs (25, 26) at 20-fold higher
concentration than required for maximal luciferase induction in control
cells (not shown).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Enforced expression of RI
or RII lowers CRE-dependent
luciferase expression in cAMP-stimulated HEK 293 cells. Panel
A shows the cAMP-induction of luciferase in cells transfected with
RI (1.4 µg), RII (1.4 µg), or control vector. The increment
due to cAMP challenge is shown by hatching. Panel
B shows the luciferase activity in cells transfected with C (4, 10, or 400 ng) with or without RI vector (1.4 µg). Panel
C shows the titration of luciferase activity induced by C (4 ng) by increasing RI vector (0.4, 1.0, and 1.7 µg). Panel
D is similar to panel A, except that all cells were
transfected with C vector (4 ng). All cells were transfected with
0.16 µg of pT81-4CRE-Luc in addition to plasmids as indicated in the
panels and above. Nineteen hours thereafter they
were exposed to cAMP challenge (30 µM forskolin, 0.25 mM 3-isobutyl-1-methylxanthine, 1 mM
8-chlorophenylthio-cAMP, 0.7 mM
N6-monobutyryl-cAMP, and 0.7 mM
N6-benzoyl-cAMP) or vehicle, and harvested
3 h thereafter for determination of luciferase activity. The data
are given as mean ± S.E. (n = 6) except for
panel C which shows the mean ± range
(n = 2-4).
|
|
There was no evidence that RI
expression had interfered
nonspecifically with luciferase expression, since co-transfection with
400 ng of C
expression plasmid could override the effect (Fig.
1B). The effect of expressed exogenous RI and C subunits could be mutually titrated in cells not stimulated with cAMP agonists (Fig. 1, B and C), confirming that the CRE-Luc
expression system responded to C
subunit and that the C
effect
could be blocked by R subunit.
The luciferase induction was next compared between cells with near
balanced coexpression of exogenous R and C
and cells with moderate
overexpression of C
alone. Again, cells with enforced expression of
RI
or RII
had lower response to cAMP challenge (Fig.
1D). This suggested that overexpressed R could inhibit the ability of exogenous (Fig. 1D) as well as of endogenous
(Fig. 1A) C
to induce CRE-governed luciferase.
The observed effects of enforced expression of R subunits in
cAMP-stimulated cells were statistically significant. The Wilcoxon signed-rank test showed significantly less cAMP-stimulated luciferase expression in cells overexpressing RI (p < 0.010;
n = 10) or RII (p < 0.025;
n = 6). When including results from cells coexpressing C
subunit, the p values were <0.001 (n = 18) for RI and <0.005 (n = 12) for RII. It is
concluded that cells with enforced expression of RI
or RII
subunits of cA-PK had blunted response to maximal cAMP stimulation.
In separate experiments, in which the luciferase reporter gene was
replaced by green fluorescent protein (GFP) as reporter, about 25% of
the cells were detectably green 24 h after transfection. The
transfection efficiency was not affected by co-transfection with RI
,
RII
, or C
plasmids. GFP containing cells co-transfected with
RI
, RII
, or C
plasmids at the concentration used in the experiments shown in panels A and D of Fig. 1
were tested for content of R (RI + RII) subunit and C subunit. The
average increase of RI, C, and RII was 2.4, 2.8, and 9.5 pmol/mg
protein, respectively. In cells transfected with 400 rather than 4 ng
of C
plasmid the protein kinase activity was increased 30-fold. The
basal level of RI + RII was 3.3 pmol/mg protein, and of C subunit was
3.0 pmol/mg protein. The moderate overexpression of RI explained why it
only protected partially against 4 ng of C
plasmid and not at all
against 400 ng of C
plasmid (Fig. 1B). It also suggested that RI might be more efficient than RII in preventing the C subunit to
stimulate gene transcription in cells with strongly increased cAMP level.
cA-PKI Holoenzyme Can Form at Submicromolar Concentrations of RI
and C Subunits in the Presence of cAMP--
The results of Fig. 1
suggested that the RI subunit of cA-PKI could sequester the C subunit
even in maximally cAMP-stimulated intact cells. This was unexpected in
view of previous estimates of the dissociation constant of the complex
between cAMP-saturated RI and the C subunit (11, 27). It was therefore
decided to study in detail the strength of the interaction between
cAMP-saturated RI and C under physiologically relevant conditions using
isolated protein kinase subunits.
One approach used the ability of C-FITC to enhance the emission of
RI-TRITC and RI-TRITC to quench the emission of C-FITC when at close
distance (FRET) (2). The fraction of C-FITC in complex with RI-TRITC
was calculated from the relative emissions at 510 and 580 nm, as
detailed in Table I. Using this method, an apparent equilibrium Kd of 0.24 µM
was determined for the complex between RI-TRITC and C-FITC in the
presence of a saturating concentration of cAMP (Fig.
2).
View this table:
[in this window]
[in a new window]
|
Table I
Determination of the fractional association of RI -TRITC (RI ) and
C -FITC (C ) by fluorescence resonance energy transfer analysis
The FITC-labeled bC subunit (30 nM) and the
TRITC-labeled bRI subunit (50 or 500 nM) were excited at
490 nm, and the emission monitored (cps) at 510 and 580 nm. The
emission at 510 nm was due to C alone, since RI did not emit at
this wavelength. At 580-nm C had significant emission (15.6% of
that at 510 nm) which was subtracted to obtain the emission due to
RI only (column 3 from the right). The ratio of emission 510/580 nm
(C /RI ) is shown for the separated subunits
(rdiss), and for combined subunits in the presence
(rx) and absence (rholo) of 50 µM cAMP. The rdiss represents the
completely dissociated state (fractional association = 0), and
rholo the completely associated holoenzyme state
(fractional association = 1.0). The fractional association
observed in the presence of cAMP was determined as shown in the right
hand column. The experiment was conducted at 25 °C in buffer A.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
The association of FITC-labeled
C subunit with cAMP saturated TRITC-labeled
RI subunit of cAMP kinase determined by
fluorescence resonance energy transfer. The data shown are from a
typical experiment conducted like that shown in Table I, with constant
concentration (30 nM) of C -FITC and increasing
concentrations of RI -TRITC at 50 µM cAMP. The
fractional association was determined as described in Table I, and was
half-maximal at 0.24 µM of added RI -TRITC.
|
|
This Kd value was surprisingly low in
view of previous estimates, and could be due to enhancement of the R-C
binding by the introduction of the fluorescent groups. In a second
approach we used biotin-labeled C
and unlabeled RI subunit. The
biotin labeling of the C subunit was performed when the C was in cA-PKI holoenzyme complex and the coupling chemistry was different from that
used for the C-FITC labeling. Biotin-C
was immobilized to streptavidin-coated wells of a microplate with intrinsic solid scintillant (and scintillation proximity assay). The added
RI·[3H]cAMP complex was detected only when close to the
wall (bound to biotinylated C). The immobilized C subunit was estimated
to be half-maximally saturated by 0.16 µM
RI-[3H]cAMP (Fig. 3),
confirming the high affinity between RI-cAMP and C subunit.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 3.
The association of
[3H]cAMP-RI to
C as determined by scintillation proximity
assay. Biotinylated C subunit was bound to streptavidin-coated
wells of a microplate with solid scintillant ("flashplate"). The
figure shows the increase of well associated radioactivity as a
function of increasing [3H]cAMP-RI added to the well.
[3H]cAMP was present at 3 µM in excess of
the concentration of RI -binding sites. Otherwise, conditions were as
described in the legend to Table I. The blank values (subtracted)
observed in the absence of MgATP or RI were similar to those in
wells not coated with C . They ranged from 5 to 25% of the
counts/min observed in C -coated wells incubated with
[3H]cAMP-RI and MgATP. The data shown give the
mean ± S.E. (n = 5).
|
|
A third method relied on unlabeled native R and C subunits. A trace
amount of C
(50 pM) was injected into size exclusion FPLC columns equilibrated with 100 µM cAMP and various
concentrations of hRI
. The position where the C subunit kinase
activity eluted was determined. Half-maximal shift of C
elution
position occurred when the column was equilibrated with 0.25 µM hRI
(data not shown). It is concluded that the C
subunit interacts with cAMP-saturated RI
with a
Kd in the submicromolar range.
Cyclic AMP Saturated cA-PKI and II Lack Demonstrable Protein Kinase
Activity--
Since the ternary cAMP·cA-PKI complex
(cAMP4, RI
2, and C
2)
apparently could form in intact cells (Fig. 1) and at submicromolar concentrations of cA-PKI subunits (Figs. 2 and 3), the question of the
catalytic activity of the ternary complex has biological importance. We
investigated this possibility using several substrates. In the first
series of experiments the C
-catalyzed phosphorylation of the
physiological substrate phenylalanine-4-monooxygenase was studied at
various concentrations of RI
in the presence of a very high
concentration (100 µM) of cAMP. At the highest
concentration (30 µM) of cAMP-saturated RI
studied the
phosphorylation rate was inhibited more than 99% (Fig.
4A). This shows that C
in
the ternary complex with cAMP-saturated RI expressed less than 1% of
its potential phosphotransferase activity, and possibly had no activity
at all. Half-maximal inhibition of the phosphorylation was observed at
0.32 µM cAMP-saturated RI
(Fig. 4B), in
line with the physicochemical data indicating a submicromolar
Kd for the complex between C
and cAMP-saturated
RI
(see above). Qualitatively similar results were obtained when the
C
activity was determined with tyrosine-4-monooxygenase as the
substrate, using autoradiography to detect the phosphorylated protein
(Fig. 5). The phosphorylation of
tyrosine-4-monooxygenase in the presence of cAMP (100 µM)
was inhibited by at least 95% also by RII
(Fig. 5).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
Inhibition of C
catalyzed phosphorylation of PAH by RI
at saturating concentration of cAMP. Panel A shows the
time kinetics of PAH (4 µM) phosphorylation by 0.3 µM C subunit in the absence of RI ( ), and in the
presence of 1.25 µM ( ) or 30 µM ( )
RI . Panel B shows the inhibition of C subunit activity by
increasing concentrations of cAMP-saturated RI . Incubation
conditions were as described in the legend for Table I, except that the
temperature was 37 °C, and [32P]ATP (2.5 µCi/ml) was
present. The data were based on initial kinase activities, under the
condition of the experiment in panel A ( , , and )
or experiments conducted with 0.3 nM C subunit ( ),
and incubation times from 1 to 12 h. Half-maximal inhibition of
PAH phosphorylation was observed at 0.32 µM RI . At 30 µM RI the PAH phosphorylation rate was 0.8% of that
observed in the absence of RI .
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Cyclic AMP-saturated RI
and RII inhibit the C
catalyzed phosphorylation of TH under near physiological
conditions. TH (5 µM) was phosphorylated for 15 min
at 37 °C in the presence of 0.7 nM C subunit and 50 µM cAMP under conditions like described in the legend to
Fig. 4. After separation by SDS-PAGE, [32P]TH and
32P-RII was detected by autoradiography. The four
left lanes show decreasing [32P]TH in samples
incubated with increasing RI . The right-hand lane shows
decreased [32P]TH in sample incubated with RII . Note
the presence of 32P-RII .
|
|
RI
and RII
(10 µM) inhibited the kinase to a
similar degree whether the free cAMP concentration was 50, 100, 300, or
600 µM. This suggested that 50-100 µM
cAMP, as routinely used, could saturate cA-PKI and II holoenzyme nearly completely.
Although cAMP-saturated cA-PKI or II holoenzyme had insignificant
activity toward large physiological protein substrates (Figs. 4 and 5),
the possibility remained that they could phosphorylate smaller
substrates (15). In our hands, RI
(Fig.
6), as well as RII
(Fig.
7), could inhibit Kemptide
phosphorylation nearly completely in the presence of cAMP. The
inhibition was reversible and similar whether bovine or human RI
was
used, and whether the R subunit was a GST fusion protein, a
thrombin-cleaved product of the latter, or was polyhistidine-tagged
(not shown).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
The inhibition of kinase activity by
cAMP-RI at various peptide substrate
concentrations. Kemptide at 8 ( ), 70 ( ), and 140 ( )
µM was phosphorylated by 0.3 nM C at
37 °C, at various concentrations of RI subunit in the presence of
50 µM cAMP. For 70 µM Kemptide, the data
represent the mean of seven separate experiments, and the error
bars represent S.E. For 8 and 140 µM Kemptide, the
data shown are mean values from two experiments.
|
|

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 7.
C mediated
phosphorylation of the high-affinity substrate Kemptide is inhibited by
micromolar concentrations of cAMP-saturated
hRII . Kemptide (100 µM) was
phosphorylated by C subunit as described in the legend to Fig. 6,
except that hRII was present at 0.01, 1, and 10 µM.
The kinase activity is given as a fraction of the activity observed in
the absence of RII subunit. Note that 1 µM RII was
sufficient to inhibit the kinase about 50%. The data shown represent
the mean + S.E. (n = 7).
|
|
Estimation of the Stability of the Ternary Complexes of
cAMP·RI
·C
and cAMP·RII
·C
at Assumed Physiological
Substrate Concentration--
A final experiment was designed to test
if more RI
was required to inhibit the kinase activity when the
substrate concentration was increased, as expected if substrate and R
subunit compete for binding to the C subunit. Elevation of the Kemptide
concentration from 8 µM through 70 µM to
140 µM increased the concentration of cAMP-saturated
RI
required for half-maximal inhibition of C
from 0.47 µM through 0.81 µM to 1.2 µM
(Fig. 6). At 100 µM Kemptide about 1 µM
RII
was required to half-maximally inhibit the kinase (Fig. 7). The
Km value for Kemptide was determined to be 11 µM, and at 100 µM Kemptide the activity was
about 90% of Vmax, suggesting 90% occupation
of the C subunit by substrate (not shown). It is concluded that 1 µM cAMP-saturated RI
or RII
is sufficient to
achieve 50% kinase inhibition, even at substrate concentrations 10 times above the Km value. The data were obtained
with RII
subunit in the dephospho-form. In separate experiments
using RII
phosphorylated by the C subunit, a higher concentration of
cAMP-saturated RII was required to inhibit the C subunit (not shown).
From previously published data it can be estimated that the C subunit
in cAMP-stimulated hepatocytes is at most 90% saturated with
substrate, and that the concentrations of C subunit and R subunit (RI + RII) is about 0.5 µM in the average cell (see the last
paragraph under "Experimental Procedures"). The dissociation of
ternary cA-PK holoenzyme complex occurs according to the equation:
[R(cAMP)2]·[C]/[R(cAMP)2C] = Kd. Assuming 90% saturation of C subunit by
substrate, a Kd = 1 µM can be
estimated from the kinetic data of Figs. 6 and 7. Assuming further that
[R] = [C] = 0.5 µM (see above), it follows that about one-fourth of the C subunit can exist as ternary complex in an average
maximally cAMP-stimulated cell if the R subunit is RI
or
dephospho-RII. The equation predicts half of the kinase to be in
ternary complex if the R subunit concentration is increased from
0.5 to 1.25 µM.
 |
DISCUSSION |
The ternary (cAMP saturated) cA-PK holoenzyme complex has received
little attention, presumably because it traditionally has been
considered too unstable to exist at appreciable concentrations in
living cells (11). We used the CRE-luciferase reporter gene to probe
for dissociation of cA-PK in intact cells. To our initial surprise,
cells with enforced expression of RI
or RII
showed decreased
expression of luciferase, even at extremely high concentrations of cAMP
analogs and agents raising the endogenous cAMP level. This suggested
that formation of cAMP-saturated cA-PKI and cA-PKII significantly
impeded nuclear influx of C subunit. The intact cell data were
supported by results obtained with isolated cA-PKI subunits under near
physiological conditions in the presence of cAMP. As judged by three
independent biophysical methods, formation of ternary complex of C
with cAMP-saturated RI
subunit occurred with an apparent
Kd in the submicromolar range.
Since the ternary complex was more stable than previously recognized,
the question of its catalytic activity becomes biologically important.
An intriguing possibility is that R-C holoenzyme associated with
scaffolding protein (AKAP), and thereby in immediate contact with
AKAP-tethered substrate (16, 17), may be retained in an active
holoenzyme complex close to the substrate upon cAMP activation (15).
The present study failed to demonstrate any significant kinase activity
of C
in ternary complex with cAMP and RI
toward the heptapeptide
Kemptide or physiological substrates (phenylalanine-4-monooxygenase and
tyrosine-4-monooxygenase). Neither did cAMP-saturated cA-PKII
holoenzyme show demonstrable catalytic activity. These results were
reproduced with a number of different preparations of R and C subunits,
and under a variety of conditions, including close to physiological
with respect to temperature, pH, and ionic strength. We conclude that
dissociation is a prerequisite for both cA-PKII and cA-PKI to catalyze
substrate phosphorylation, at least under physiologically relevant
conditions in vitro. Obviously, cAMP-saturated cA-PKI
and cA-PKII differ from cyclic nucleotide-saturated
cGMP-dependent protein kinase in this respect (12). An
early report (11) suggested that the ternary complex between cAMP, RII,
and C subunit had about 15% of the activity of the free C subunit. A
more recent study (15) found the ternary complex between cAMP, RII, and
fluorescein-labeled C subunit to have full catalytic activity toward
Kemptide. A possible explanation of this discrepancy may be that C
subunit labeled with fluorescein-succinimidyl ester (15) has poor
ability to interact with RI subunit (4) and may have subtly altered
interaction with RII as well, allowing cA-PKII holoenzyme formation
without kinase inhibition. It is known that point mutations of C
can affect binding to either RI or RII, without interfering with the catalytic activity (28).
The ternary complex of C subunit with cAMP and R was destabilized by
protein kinase substrate (Fig. 6). We envisage therefore that substrate
depletion due to phosphorylation, by allowing more C subunit to be
sequestered in ternary complex, may act as a negative feedback
mechanism of kinase activity. Experimental verification of this
possibility is hampered by the instability of the FRET signal used to
monitor cA-PK dissociation in intact cells, due to photobleaching and
nuclear translocation of the C subunit. We note, however, that Zaccolo
et al. (3) reported the FRET signal typical of cA-PKII
dissociation to decrease with time in some Chinese hamster ovary cells
continuously exposed to a maximal cAMP stimulus.
Extrapolation from the in vitro data suggests that about
one-fourth of the C subunit can be sequestered as inactive,
cAMP-saturated cA-PK (ternary complex) in the average cAMP-stimulated
cell. This allows a novel avenue for control of the cA-PK activity in
maximally cAMP stimulated cells, through regulation of the R subunit
level. Up-regulation of R subunit will sequester more C subunit as
inactive complex, and down-regulation of R will release kinase from the ternary complex. Such regulation will not be possible if it is assumed
that all cA-PK is dissociated in maximally cAMP-stimulated cells. The
decreased CRE-mediated gene expression in cells overexpressing RI
or
RII
(Fig. 1) is not readily explained without invoking ternary
complex formation. Since overexpressed R subunit is not taken up by
nuclei (3, 29), the effect is best explained by assuming sequestration
of C subunit in a ternary complex in the cytoplasm. In retrospect,
ternary complex formation can explain our previous observation of
relatively more holoenzyme-associated kinase than expected from the
tissue cAMP level during the pre-replicative cAMP surge in the
regenerating liver, in which both RI and RII were up-regulated (7).
Similarly, ternary complex formation may explain the attenuated
cAMP-stimulated gene induction in C/EBP
null mice, which have
increased RI and RII (5). It may also explain the deficient
cAMP-stimulated CREB phosphorylation and CRE-dependent gene
expression in protein kinase inhibitor null mice, which have 50%
increase of RI
.
Selective degradation of the free cAMP-complexed R subunit (30) will,
in contrast to the above examples of R up-regulation, serve to further
enhance the kinase activity in maximally cAMP-stimulated cells. An
intriguing example is found in Aplysia neurons exposed to
5-hydroxytryptamine. In these cells the cAMP level remains elevated for
2 h, during which time R subunit degradation (about 20%) must
occur to ensure enough CRE-dependent gene transcription to
establish long term potentiation (31). The current view is that
degradation of R renders the Aplysia cA-PK independent of cAMP (31, 32). This may be an oversimplification, since
Rp-cAMPS, which acts by promoting R-C
association by displacing cAMP (12, 33), blocked potentiation, even
when given several hours after the cAMP stimulus (34).
Aplysia and mammalian cA-PK appear basically similar (31,
35). The possibility should therefore be considered that R degradation
in Aplysia amplifies cAMP action by allowing more C subunit
to escape ternary complex formation both during the acute cAMP
stimulation and thereafter.
In conclusion, the ternary complex of C
with cAMP-saturated RI
or
RII
was devoid of catalytic activity against relevant substrates.
The ternary complexes had higher in vitro stability than
previously recognized. Extrapolation from in vitro data
predicted a significant proportion of C subunit to be in the
cytoplasmic ternary complex in maximally cAMP stimulated normal cells,
and an even higher proportion in cells overexpressing RI
or RII
. Ternary complex formation is predicted to decrease nuclear accumulation of C subunit and thereby CRE-dependent gene expression, and
offered the only rational explanation of the experimentally observed
lowered CRE-luciferase expression in cells overexpressing RI
or
RII
. Modulation of ternary complex formation represents, to our
knowledge, the only way of tuning cAMP-dependent protein
kinase activity in maximally cAMP-stimulated cells. Such modulation may
occur through altered substrate availability or regulation of the
cellular content of R subunit.
 |
ACKNOWLEDGEMENT |
We thank Kirsten Brønstad for assistance in
purifying the regulatory subunits.
 |
FOOTNOTES |
*
This work was supported by The Norwegian Research Council
(NFR), The Novo Nordisk Insulin Foundation, and The Norwegian Cancer Society (DNK).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Both authors contributed equally to this work.
§
To whom correspondence should be addressed: Dept. of Anatomy and
Cell Biology, University of Bergen, Årstadveien 19, N-5009 Bergen,
Norway. Tel.: 47-55-58-63-76; Fax: 47-55-58-63-60; E-mail: stein.
doskeland@iac.uib.no.
Published, JBC Papers in Press, February 7, 2002, DOI 10.1074/jbc.M109869200
 |
ABBREVIATIONS |
The abbreviations used are:
cA-PK I and II, cAMP-dependent protein kinase I and II;
GST, glutathione
S-transferase;
FITC, fluorescein 5-isothiocyanate;
TRITC, tetramethylrhodamine-5-isothiocyanate;
CREB, cAMP-response
element-binding protein, AKAP, cA-PK anchoring proteins;
PAH, phenylalanine 4-monooxygenase;
TH, tyrosine 4-monooxygenase;
FPLC, fast
protein liquid chromatography;
FRET, fluorescence energy transfer;
GFP, green fluorescent protein.
 |
REFERENCES |
| 1.
|
Builder, S. E.,
Beavo, J. A.,
and Krebs, E. G.
(1980)
J. Biol. Chem.
255,
3514-3519[Free Full Text]
|
| 2.
|
Adams, S. R.,
Harootunian, A. T.,
Buechler, Y. J.,
Taylor, S. S.,
and Tsien, R. Y.
(1991)
Nature
349,
694-697[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Zaccolo, M., De,
Giorgi, F.,
Cho, C. Y.,
Feng, L.,
Knapp, T.,
Negulescu, P. A.,
Taylor, S. S.,
Tsien, R. Y.,
and Pozzan, T.
(2000)
Nat. Cell Biol.
2,
25-29[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Adams, S. R.,
Bacskai, B. J.,
Taylor, S. S.,
and Tsien, R. Y.
(1999)
in
Fluorescence and Luminescent Probes for Biological Activity
(Mason, W. T., ed), 2nd Ed.
, pp. 156-172, Academic Press, Harcourt Brace & Co., UK
|
| 5.
|
Croniger, C. M.,
Millward, C.,
Yang, J.,
Kawai, Y.,
Arinze, I. J.,
Liu, S.,
Harada-Shiba, M.,
Chakravarty, K.,
Friedman, J. E.,
Poli, V.,
and Hanson, R. W.
(2001)
J. Biol. Chem.
276,
629-638[Abstract/Free Full Text]
|
| 6.
|
Gangolli, E. A.,
Belyamani, M.,
Muchinsky, S.,
Narula, A.,
Burton, K. A.,
McKnight, G. S.,
Uhler, M. D.,
and Idzerda, R. L.
(2000)
Mol. Cell. Biol.
20,
3442-3448[Abstract/Free Full Text]
|
| 7.
|
Ekanger, R.,
Vintermyr, O. K.,
Houge, G.,
Sand, T. E.,
Scott, J. D.,
Krebs, E. G.,
Eikhom, T. S.,
Christoffersen, T.,
Ogreid, D.,
and Doskeland, S. O.
(1989)
J. Biol. Chem.
264,
4374-4382[Abstract/Free Full Text]
|
| 8.
|
Mayr, B.,
and Montminy, M.
(2001)
Nat. Rev. Mol. Cell. Biol.
2,
599-609[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Hagiwara, M.,
Brindle, P.,
Harootunian, A.,
Armstrong, R.,
Rivier, J.,
Vale, W.,
Tsien, R.,
and Montminy, M. R.
(1993)
Mol. Cell. Biol.
13,
4852-4859[Abstract/Free Full Text]
|
| 10.
|
Sassone-Corsi, P.
(1998)
Int. J. Biochem. Cell Biol.
30,
27-38[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Builder, S. E.,
Beavo, J. A.,
and Krebs, E. G.
(1980)
Cold Spring Harbor Symp. Quant. Biol
8,
33-43
|
| 12.
|
Francis, S. H.,
and Corbin, J. D.
(1999)
Crit. Rev. Clin. Lab. Sci.
36,
275-328[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Honda, A.,
Adams, S. R.,
Sawyer, C. L.,
Lev-Ram, V.,
Tsien, R. Y.,
and Dostmann, W. R.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
2437-2442[Abstract/Free Full Text]
|
| 14.
|
Wang, Y.,
Scott, J. D.,
McKnight, G. S.,
and Krebs, E. G.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
2446-2450[Abstract/Free Full Text]
|
| 15.
|
Yang, S.,
Fletcher, W. H.,
and Johnson, D. A.
(1995)
Biochemistry
34,
6267-6271[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Colledge, M.,
and Scott, J. D.
(1999)
Trends Cell Biol.
9,
216-221[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Feliciello, A.,
Gottesman, M. E.,
and Avvedimento, E. V.
(2001)
J. Mol. Biol.
308,
99-114[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Feliciello, A.,
Gallo, A.,
Mele, E.,
Porcellini, A.,
Troncone, G.,
Garbi, C.,
Gottesman, M. E.,
and Avvedimento, E. V.
(2000)
J. Biol. Chem.
275,
303-311[Abstract/Free Full Text]
|
| 19.
|
Saraswat, L. D.,
Filutowicz, M.,
and Taylor, S. S.
(1986)
J. Biol. Chem.
261,
11091-11096[Abstract/Free Full Text]
|
| 20.
|
Roskoski, R., Jr.
(1983)
Methods Enzymol.
99,
3-6[Medline]
[Order article via Infotrieve]
|
| 21.
|
Doskeland, A. P.,
Vintermyr, O. K.,
Flatmark, T.,
Cotton, R. G.,
and Doskeland, S. O.
(1992)
Eur. J. Biochem.
206,
161-170[Medline]
[Order article via Infotrieve]
|
| 22.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Doskeland, S. O.,
and Ogreid, D.
(1988)
Methods Enzymol.
159,
147-150[Medline]
[Order article via Infotrieve]
|
| 24.
|
Hofmann, F.,
Bechtel, P. J.,
and Krebs, E. G.
(1977)
J. Biol. Chem.
252,
1441-1447[Abstract/Free Full Text]
|
| 25.
|
Schultz, C.,
Vajanaphanich, M.,
Harootunian, A. T.,
Sammak, P. J.,
Barrett, K. E.,
and Tsien, R. Y.
(1993)
J. Biol. Chem.
268,
6316-6322[Abstract/Free Full Text]
|
| 26.
|
Schultz, C.,
Vajanaphanich, M.,
Genieser, H. G.,
Jastorff, B.,
Barrett, K. E.,
and Tsien, R. Y.
(1994)
Mol. Pharmacol.
46,
702-708[Abstract]
|
| 27.
|
Doskeland, S. O.,
Maronde, E.,
and Gjertsen, B. T.
(1993)
Biochim. Biophys. Acta
1178,
249-258[Medline]
[Order article via Infotrieve]
|
| 28.
|
Cheng, X.,
Phelps, C.,
and Taylor, S. S.
(2001)
J. Biol. Chem.
276,
4102-4108[Abstract/Free Full Text]
|
| 29.
|
Wiley, J. C.,
Wailes, L. A.,
Idzerda, R. L.,
and McKnight, G. S.
(1999)
J. Biol. Chem.
274,
6381-6387[Abstract/Free Full Text]
|
| 30.
|
Krebs, E. G.,
and Graves, J. D.
(2000)
Adv. Enzyme. Regul.
40,
441-470[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Chain, D. G.,
Casadio, A.,
Schacher, S.,
Hegde, A. N.,
Valbrun, M.,
Yamamoto, N.,
Goldberg, A. L.,
Bartsch, D.,
Kandel, E. R.,
and Schwartz, J. H.
(1999)
Neuron
22,
147-156[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Hegde, A. N.,
Goldberg, A. L.,
and Schwartz, J. H.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
7436-7440[Abstract/Free Full Text]
|
| 33.
|
Gjertsen, B. T.,
Mellgren, G.,
Otten, A.,
Maronde, E.,
Genieser, H. G.,
Jastorff, B.,
Vintermyr, O. K.,
McKnight, G. S.,
and Doskeland, S. O.
(1995)
J. Biol. Chem.
270,
20599-20607[Abstract/Free Full Text]
|
| 34.
|
Hegde, A. N.,
Inokuchi, K.,
Pei, W.,
Casadio, A.,
Ghirardi, M.,
Chain, D. G.,
Martin, K. C.,
Kandel, E. R.,
and Schwartz, J. H.
(1997)
Cell
89,
115-126[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Chain, D. G.,
Hegde, A. N.,
Yamamoto, N.,
Liu-Marsh, B.,
and Schwartz, J. H.
(1995)
J. Neurosci.
15,
7592-7603[Abstract]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. S. Lynch and J. G. Ryall
Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Physiol Rev,
April 1, 2008;
88(2):
729 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Das and G. Melacini
A Model for Agonism and Antagonism in an Ancient and Ubiquitous cAMP-binding Domain
J. Biol. Chem.,
January 5, 2007;
282(1):
581 - 593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Dao, K. Teigen, R. Kopperud, E. Hod |